Fenofibrate

非诺贝特

Report date: 2026/05/13 20:02:10
NME

Base Information

Drug NameFenofibrate
Drug Alias Name普鲁脂芬fenofibratumCIP-Fenofibrate菲诺贝特Fenomax +[27] 
ClassificationSmall molecules
Mechanisms of ActionPeroxisome proliferator activated receptor agonists
TargetsPeroxisome proliferator activated receptor
Therapy Area/IndicationsMacular telangiectasia 2BurnsAlcoholism +[14] 
Global Approved IndicationsHypertriglyceridemiaHypercholesterolemia
Approved Indications in ChinaHypertriglyceridemiaHypercholesterolemia
Original Approved Country/TerritoryMainland China
Original Approved Date1985/01/01
Country/TerritoryUnited StatesPolandAustralia +[7] 
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesAbbvie Inc
China Registration ClassN/A

Develop Information

Active CompaniesThe Lowy Medical Research Institute LtdUniversity of California IrvineJaeb Center For Health Research Inc +[10] 
Inactive CompaniesHanmi Pharmaceutical Co LtdUniversity Of FloridaUniversity Of Texas Medical Branch +[8] 
Active IndicationsMacular telangiectasia 2HypertriglyceridemiaHypercholesterolemia +[10] 
Inactive IndicationsBurnsAlcoholismHyperlipoproteinemias +[4] 

Other Information

ATC CodeC10AB05
Related LinksWikipediaDrugBankKEGG